Showing results (61-70 of 95) with videos related to
Sort By:
Pageof 10
Oncology Research|June 12, 2023
Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cellsSandra Stickler, Barbara Rath, Maximilian Hochmair, et al.Plastic and Reconstructive Surgery|July 27, 2019
Interaction of Adipose-Derived Stromal Cells with Breast Cancer Cell LinesMaryana Teufelsbauer, Barbara Rath, Doris Moser, et al.Oncology Reports|July 29, 2003
Effects of 1alpha,25-dihydroxy-vitamin D3 pretreatment and MAP kinase inhibitor PD 98059 on response of osteoblasts to prostate-derived osteoblastic factorsErnst Ulsperger, Gerhard Hamilton, Ulrike Olszewski, et al.Anti-Cancer Agents in Medicinal Chemistry|January 24, 2012
Anticancer effects of the organosilicon multidrug resistance modulator SILA 421Ulrike Olszewski, Robert Zeillinger, Meltem Demirel Kars, et al.Wiener Klinische Wochenschrift|April 15, 2025
Markers for the angiogenic potential of fat graftsMaryana Teufelsbauer, Sandra Stickler, Marie-Therese Eggerstorfer, et al.Clinical Pharmacology : Advances and Applications|February 1, 2012
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compoundsUlrike Olszewski, Thomas Tuxen Poulsen, Ernst Ulsperger, et al.Anti-Cancer Drugs|December 20, 2021
Rovalpituzumab tesirine resistance: analysis of a corresponding small cell lung cancer and circulating tumor cell line pairBarbara Rath, Adelina Plangger, Dagmar Krenbek, et al.Metal-Based Drugs|July 10, 2009
In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer AgentUlrike Olszewski, Florian Ach, Ernst Ulsperger, et al.Investigational New Drugs|October 1, 2021
Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung CancerAdelina Plangger, Barbara Rath, Maximilian Hochmair, et al.Anticancer Research|February 29, 2024
BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell LinesClemens Lang, Sandra Stickler, Barbara Rath, et al.Pageof 10